InvestSMART

Genetic Signatures Limited (ASX: GSS) - ETF Exposure

Current share price for GSS : $0.061 0.003 (5.17%)+

Genetic Signatures Limited (GSS) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is engaged in the research and development into identifying and commercialization of molecular diagnostics products to aid in the diagnosis of infectious diseases and the sale of associated products into the diagnostic and research marketplaces.

Genetic Signatures Limited (GSS) ETFs

1 ETF hold Genetic Signatures Limited (GSS).

ETF GSS Weight MER Yield
eInvest Better Future (Managed Fund) (IMPQ) 0.3% 0.89% 2.05%

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.